Monday, September 7, 2026• Updated September 7, 2026• Medically reviewed September 7, 2026
Diabetes and Hair Loss Is There a Connection
Hair loss can occur in a person who has diabetes, but shedding alone is not a sign that someone has diabetes, and many people with diabetes do not experience hair loss. There are numerous causes of hair loss. For some patients, diabetes may be part of a wider medical and metabolic context that affects the hair-growth cycle rather than a single direct cause.
How might diabetes affect the hair cycle?
Hair follicles repeatedly move through growth, transition, and resting phases. Fever, surgery, significant physical stress, rapid weight loss, and nutritional deficiency can push a larger number of hairs into the resting phase at the same time. This diffuse shedding, called telogen effluvium, usually becomes noticeable several months after the triggering event.
Periods of difficult glucose management, infection, or other illnesses associated with diabetes can place physiological stress on the body. Long-term hyperglycemia is also associated with microvascular and neurologic complications. Even so, it is too simplistic to explain every case of scalp hair loss as a lack of oxygen reaching the follicles. The actual cause must be assessed for each patient.
What does the research show?
Some observational research has found associations between type 2 diabetes and particular forms of hair loss. In one large cohort of women, type 2 diabetes was associated with a higher risk of severe central scalp hair loss. An association does not prove that diabetes directly causes every episode of shedding, and the findings from one population cannot automatically be applied to everyone.
Pattern hair loss, thyroid disease, iron deficiency, autoimmune disease, postpartum changes, medicines, and genetic susceptibility can cause hair loss independently of diabetes. More than one factor may be present in the same person.
Can diabetes medicines cause hair loss?
Noticing shedding after starting a medicine does not establish that the medicine is the cause. The illness being treated, accompanying weight loss, dietary changes, stress, and other medicines may also contribute. Rapid weight loss in particular can trigger telogen effluvium. Clinical evidence for a direct link between GLP-1 receptor agonists and hair loss remains limited, and some reported shedding may relate to rapid weight change.
A prescribed diabetes medicine should not be stopped without speaking to the clinician managing the condition. The timing of symptoms, dose changes, weight history, nutrition, and other signs should be reviewed together.
How is hair loss assessed?
The assessment begins by determining when the loss started, whether it is diffuse or localized, and whether redness, scaling, itching, pain, or scarring is present. Current medicines, recent illnesses, weight change, diet, menstrual history, and family history may all be relevant.
Based on the examination, a clinician may request tests such as a blood count, iron studies, thyroid testing, or other targeted investigations. Diabetes should not be diagnosed from hair loss alone. Screening and diagnosis should follow current clinical criteria and take the person's overall risk factors into account.
How is treatment planned?
The priorities are to manage glucose safely with the treating clinician and identify the actual type of hair loss. Telogen effluvium often improves gradually after the trigger resolves. Pattern hair loss, alopecia areata, and inflammatory or scarring scalp disease require different treatment approaches.
Hair transplantation can be considered for some people with diabetes, but glucose control, wound healing, infection risk, circulation, and current medicines must be reviewed before surgery. Surgery should be deferred when active or unexplained shedding has not been diagnosed and stabilized.
When should you seek medical assessment?
Prompt assessment is appropriate for sudden heavy shedding, round or patchy bald areas, eyebrow or eyelash loss, scalp pain, or signs of scarring. Hair loss accompanied by excessive thirst, frequent urination, unexplained weight loss, or marked fatigue also warrants medical attention. These symptoms do not establish a diagnosis by themselves, but they should not be ignored.
- Association of type 2 diabetes with central-scalp hair loss in a large cohort study of African American womenhttps://pubmed.ncbi.nlm.nih.gov/31700983/— International Journal of Women's Dermatology
- Telogen Effluviumhttps://pubmed.ncbi.nlm.nih.gov/28613598/— StatPearls and PubMed
- Standards of Care in Diabetes 2026 Retinopathy Neuropathy and Foot Carehttps://diabetesjournals.org/care/article/49/Supplement_1/S261/163919/12-Retinopathy-Neuropathy-and-Foot-Care-Standards— American Diabetes Association
- GLP-1 agonists and hair loss: a call for further investigationhttps://pubmed.ncbi.nlm.nih.gov/38741261/— International Journal of Dermatology
- Is Every Patient of Hair Loss a Candidate for Hair Transplant?https://pmc.ncbi.nlm.nih.gov/articles/PMC8719975/— Journal of Cutaneous and Aesthetic Surgery
This page is intended for informational purposes only and does not replace professional medical advice. A physician’s evaluation and examination are required for diagnosis and treatment planning.
At Dr. Ulusan Clinic in Izmir, FUE, DHI and Sapphire hair transplants are performed with over 30 years of surgical experience.
